Table 1 Brief summary of clinical symptoms associated with each mutation.

From: microRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases

Cybrid cell name

MELAS

MERRF

m.Val

m.Trp

m.ND6

tRNA/protein and mutation

tRNA Leu m.3243 A > G (MELAS)

tRNA Lys m. 8344 A > G (MERRF)

tRNA Val m. 1643A > G

tRNA Trp m. 5514 A > G

ND6 m.14487 T > C

Organ

Clinical features

Brain

Stroke-like episodes, typically before age 40 years Encephalopathy with seizures and/or dementia Normal early psychomotor development Recurrent headache

Myoclonus Generalized epilepsy Ataxia Dementia Pyramidal signs

Normal early psychomotor development Epilepsy Brain atrophy Dyskinetic movement Dystonic tetraplegia Loss of oral communication

Reduced spontaneous movements

Progressive generalized dystonia and bilateral striatal necrosis

Nerve

Recurrent vomiting

Peripheral neuropathy

Peripheral neuropathy

Global delay in myelination Recurrent vomiting

 

Muscle

Mitochondrial myopathy, evidenced by lactic acidosis and/or ragged red fibers (RRF) on muscle biopsy

Myopathy Ragged-red fibers (RRF) in the muscle biopsy Ophthalmoparesis

Muscle atrophy Lactic acidosis

Muscle atrophy Hypotonia Lactic acidosis.

 

Heart

 

Cardiomyopathy

   

Eyes

 

Optic atrophy Pigmentary retinopathy

   

Ears

 

Sensorineural hearing loss

   

Systemic

 

Exercise intolerance Short stature Multiple lipomas

 

Low weight and height

 

Reference

23

23

24

24

25